2018 | Rab25 augments cancer cell invasiveness through a beta1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin
| EXPERIMENTAL AND MOLECULAR MEDICINE |
2022 | Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16) | GASTRIC CANCER |
2021 | Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2019 | Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer | EUROPEAN JOURNAL OF CANCER |
2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| SUPPORTIVE CARE IN CANCER |
2015 | Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
| GASTRIC CANCER |
2018 | Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial | CLINICAL CANCER RESEARCH |
2024 | Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)
| BMC CANCER |
2016 | Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
| ONCOTARGET |
2018 | Reconsideration of sample size and power calculation for overall survival in cancer clinical trials
| CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS |
2016 | Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration | JOURNAL OF SURGICAL ONCOLOGY |
2003 | Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer
| Molecular Pathology |
2016 | Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial | JOURNAL OF CLINICAL ONCOLOGY |
2018 | Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
2016 | Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity
| ONCOTARGET |
1997 | Relationship between p53 Overexpression and Gastric Cancer Progression | ONCOLOGY |
2018 | Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
| CANCERS |
2018 | Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.
| KOREAN JOURNAL OF INTERNAL MEDICINE |
1997 | Retrospective Comparison of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Modified FAM) Combination Chemotherapy Versus Palliative Therapy in Treatment of Advanced Gastric Cancer | American Journal of Clinical Oncology |
1998 | Retroviral Vector를 이용한 Herpes Simplex Virus-Thymidine Kinase 유전자의 도입과 발현이 인체 위암세포주의 Ganciclovir 감수성에 미치는 영향
| Journal of the Korean Cancer Association (대한암학회지) |
1997 | Retroviral Vector를 이용한 인체 간암세포주로의 Interleukin-2 유전자 형질도입의 효과
| Journal of the Korean Cancer Association (대한암학회지) |
2016 | Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis
| JOURNAL OF CANCER |
2006 | Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines | PHARMACOGENETICS AND GENOMICS |
2016 | Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium | CANCER |
2023 | Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea
| EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES |
2007 | Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma | ONCOLOGY |
2019 | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
| CANCER RESEARCH AND TREATMENT |
2008 | S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2023 | Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study
| MOLECULAR CANCER THERAPEUTICS |
2013 | Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program | UROLOGY |
2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2020 | Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma
| DIAGNOSTICS |
2018 | Screening audit' as a quality assurance tool in good clinical practice compliant research environments
| BMC MEDICAL ETHICS |
2024 | Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study | GASTRIC CANCER |
2022 | Self-efficacy for coping with cancer and quality of life in advanced gastric cancer patients | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
1996 | Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression | CLINICAL & EXPERIMENTAL METASTASIS |
1997 | Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression | BREAST CANCER RESEARCH AND TREATMENT |
2021 | SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence
| GASTRIC CANCER |
2015 | Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas | GUT |
2019 | Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
| YONSEI MEDICAL JOURNAL |
2006 | Significant Gene Selection Using Integrated Microarray Data Set with Batch Effect
| Genomics & Informatics |
2023 | Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study | HEPATOLOGY |
2008 | SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis.
| BMC BIOINFORMATICS |
2023 | Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
| NEW ENGLAND JOURNAL OF MEDICINE |
2019 | Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy | SUPPORTIVE CARE IN CANCER |
2021 | Stable Symptom Clusters and Evolving Symptom Networks in Relation to Chemotherapy Cycles | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT |
2004 | Statistical methods of determining a cut off value between normal and disease groups
| Bulletin of Informatics and Cybernetics |
2023 | Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20)
| CANCER RESEARCH AND TREATMENT |
2009 | Subtelomeric DNA methylation and telomere length in human cancer cells | CANCER LETTERS |
2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
2008 | Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
| ANNALS OF ONCOLOGY |
2014 | Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. | EUROPEAN UROLOGY |
2017 | Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life | SUPPORTIVE CARE IN CANCER |
1998 | Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progression
| YONSEI MEDICAL JOURNAL |
2020 | Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells
| YONSEI MEDICAL JOURNAL |
2011 | Systematic analyses of genes associated with radiosensitizing effect by celecoxib, a specific cyclooxygenase-2 inhibitor
| JOURNAL OF RADIATION RESEARCH |
2006 | Systematic analysis of cDNA microarray-based CGH. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
1998 | Telomerase Activity and Telomere Lengths in Various Cell Lines: Changes of Telomerase Activity Can Be Another Method for Chemosensitivity Evaluation | INTERNATIONAL JOURNAL OF ONCOLOGY |
2017 | Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
2013 | Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |